ALEXANDRIA VENTURE​ INVESTMENTS

Since our inception in 1996, Alexandria Venture Investments has actively invested in disruptive life science companies that are advancing transformative new modalities, platforms, and innovative medicines to meaningfully improve human health.

Supporting Trailblazing Companies at the Forefront of Innovation

We are proud of our over 25-year history of investing in highly disruptive companies pioneering cutting-edge therapeutic platforms that respond to the urgent needs of patients around the world, including our early investments in Alnylam Pharmaceuticals, ​ Moderna, and Intra-Cellular Therapies.
We invest in seed-, early-, and growth-stage companies catalyzing the next generation of groundbreaking therapeutic platforms with immense potential to address a wide array of diseases, and ultimately fulfill Alexandria’s mission to advance human health by curing disease and improving nutrition.

In our dedication to partnering with trailblazing companies to support the development of new treatments and cures, Alexandria Venture Investments provides select LaunchLabs member companies with access to capital.

OUR TRACK RECORD

1996​

founded​

~$1.2B 


UNDER MANAGEMENT

alnylam
moderna
INTRA-CELLULAR

Notable early investments

Alexandria Seed Capital Platform™

Created and led by Alexandria Venture Investments, the Alexandria Seed Capital Platform is an innovative funding model that brings together leaders from the life science community to catalyze early-stage investment in cutting-edge companies across Alexandria’s cluster ecosystems.

The platform’s preeminent Advisory Board consists of seasoned biopharma and venture capital executives committed to enhancing ​ early-stage life science investment momentum to accelerate transformative discoveries in biomedicine.

Apply TO LAUNCHLABS